SCHEMBL3379391

SCHEMBL3379391

COc1c(C)cnc(CSc2nc3ccccc3n2OC)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 1/20 0.48
BRS3 P32247 1/20 0.47
KMT2A Q03164 3/20 0.43
WDR5 P61964 1/20 0.43
HTT P42858 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
MAPT P10636 4/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2D6 P10635 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
MEN1 O00255 2/20 0.41
CYP3A4 P08684 1/20 0.41
AGXT P21549 1/20 0.41
PDE10A Q9Y233 1/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10584394 0.84 SHMT2 (0.47) SHMT2BRS3KMT2AWDR5HPGD
SCHEMBL14356330 0.81 HPGD (0.48) SHMT2BRS3KMT2AWDR5HTT
SCHEMBL20387986 0.79 SHMT2 (0.42) SHMT2BRS3KMT2AWDR5ALDH1A1
SCHEMBL5197626 0.77 KMT2A (0.41) SHMT2BRS3KMT2AWDR5HTT
SCHEMBL4958916 0.77 KMT2A (0.41) SHMT2BRS3KMT2AWDR5HTT
Water SCHEMBL4555319 0.75 KMT2A (0.40) SHMT2BRS3KMT2AWDR5HTT
SCHEMBL6474161 0.75 SHMT2 (0.51) SHMT2BRS3KMT2AWDR5HTT
SCHEMBL10866252 0.74 SHMT2 (0.49) SHMT2BRS3KMT2AWDR5HTT
SCHEMBL10578851 0.74 BRS3 (0.74) SHMT2BRS3KMT2AWDR5HTT
SCHEMBL10867894 0.74 SHMT2 (0.72) SHMT2BRS3KMT2AWDR5HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0773940-B2 PROCESS FOR SYNTHESIS OF SUBSTITUTED SULPHOXIDES ASTRAZENECA AB (SE) 2010-11-17 EP disclosed
EP-2106397-A1 A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE ESOMEPRAZOLE Hetero Drugs Limited (IN) 2009-10-07 EP disclosed
WO-2009040825-A1 A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE ESOMEPRAZOLE HETERO DRUGS LIMITED (IN) 2009-04-02 WO disclosed
EP-0773940-B1 PROCESS FOR SYNTHESIS OF SUBSTITUTED SULPHOXIDES ASTRAZENECA AB (SE) 2003-06-04 EP disclosed